CV Sciences (OTC: CVSI) is a life science company focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol (CBD). The company operates through two segments: specialty pharmaceutical and consumer product. It also manufactures, markets and sells plant-based CBD products under PlusCBD brand for a range of market sectors, including nutraceutical, beauty care, specialty foods and vape. For more information, visit the company’s website at www.cvsciences.com.
About CannabisNewsWire
CannabisNewsWire (CNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, CNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.
For more information, visit https://www.cannabisnewswire.com
Please see full disclaimers on the CannabisNewsWire website: http://nnw.fm/Disclaimer
CannabisNewsWire (CNW)
Denver, CO
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com